Oxydifficidin, a potent Neisseria gonorrhoeae antibiotic due to DedA assisted uptake and ribosomal protein RplL sensitivity

Author:

Kan Jingbo123,Morales Adrian1,Hernandez Yozen1,Ternei Melinda A1,Lemetre Christophe1,Maclntyre Logan W1,Biais Nicolas234,Brady Sean F1ORCID

Affiliation:

1. Laboratory of Genetically Encoded Small Molecules, The Rockefeller University

2. Graduate Center, City University of New York

3. Brooklyn College, City University of New York

4. Laboratoire Jean Perrin, UMR 8237 Sorbonne Université/CNRS

Abstract

Gonorrhea, which is caused by Neisseria gonorrhoeae , is the second most prevalent sexually transmitted infection worldwide. The increasing appearance of isolates that are resistant to approved therapeutics raises the concern that gonorrhea may become untreatable. Here, we serendipitously identified oxydifficidin as a potent N. gonorrhoeae antibiotic through the observation of a Bacillus amyloliquefaciens contaminant in a lawn of N. gonorrhoeae . Oxydifficidin is active against both wild-type and multidrug-resistant N. gonorrhoeae . It’s potent activity results from a combination of DedA-assisted uptake into the cytoplasm and the presence of an oxydifficidin-sensitive ribosomal protein L7/L12 (RplL). Our data indicates that oxydifficidin binds to the ribosome at a site that is distinct from other antibiotics and that L7/L12 is uniquely associated with its mode of action. This study opens a potential new avenue for addressing antibiotic resistant gonorrhea and underscores the possibility of identifying overlooked natural products from cultured bacteria, particularly those with activity against previously understudied pathogens.

Publisher

eLife Sciences Publications, Ltd

Reference45 articles.

1. G. World Health Organization. 2019. Prevention and control of sexually transmitted infections (STIs) in the era of oral pre-exposure prophylaxis (PrEP) for HIV.

2. Update to CDC’s Treatment Guidelines for Gonococcal Infection;MMWR Morb Mortal Wkly Rep,2020

3. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure;Antimicrob Agents Chemother,2012

4. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan;Emerg Infect Dis,2011

5. Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom, December 2021 to June 2022;Euro Surveill,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3